kinesin


Also found in: Dictionary, Medical, Wikipedia.

kinesin

[kī′nēs·ən]
(cell and molecular biology)
An enzyme that hydrolyzes adenosine triphosphate to provide energy to power anterograde [from (-) to (+)] movement along microtubules.
Mentioned in ?
References in periodicals archive ?
Creation of the neural structure, unachievable by normal manufacturing techniques, begins by altering the behavior of kinesin motor proteins -- biological machines found in every human cell.
RNA-binding proteins (RBPs), kinesin motor proteins, mRNAs and noncoding RNAs (ncRNAs) are involved in dendritic mRNA transport and translational regulation.
SEATTLE, May 15, 2014 /PRNewswire-USNewswire/ -- Known for its advocacy of intelligent design, Discovery Institute has released The Workhorse of the Cell: Kinesin, a dramatic new three-minute video revealing what could be the most visually stunning molecular machines in cells, called kinesins.
The Company's pipeline includes ARQ 087, designed to inhibit fibroblast growth factor receptor, ARQ 621, designed to inhibit the Eg5 kinesin motor protein, and ARQ 736, designed to inhibit the RAF kinases.
Specific topics include molecular dynamics simulation studies of couples protein and water dynamics, heat transfer in nanostructures, energy flow pathways in photoreceptor proteins, and the chemo-mechanical coupling mechanisms of kinesin and dynein.
The strategic alliance, initiated in June 2001, included a minimum five year research term, which has generated two drug candidates that inhibit kinesin spindle protein (KSP), ispinesib and SB-743921, and a potential drug candidate, GSK-923295, which targets CENP-E.
Located within dendrites and axonal projections, microtubules serve as tracks for the transportation of post-Golgi vesicles by microtubule bound motor proteins (such as kinesin and dynein).
Within living calls, a two-headed protein called kinesin acts as a biological motor, hauling cargo.
Tokyo, Japan, Jan 11, 2006 - (JCN) - Kyowa Hakko Kogyo announced on January 10 that it has signed a licensing agreement with US pharmaceutical company Eli Lilly on mitotic kinesin Eg5 inhibitor, Kyowa Hakko's proprietary compound for anti-tumor agents.
A kinesin like calmodulin binding protein (KCBP) is a unique microtubule motor protein originally discovered in flowering plants that contains two microtubule-binding sites, myosin tail homology, and a regulatory calcium/ calmodulin-binding domain.
Several members of the kinesin motor family are selectively moving into axons, presumably guided by the specific organisation of the neuronal microtubule cytoskeleton.
The scientists filled the vesicals with microtubules, tube-shaped components of the cytoskeleton, and kinesin molecules.